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ABSTRACT
Conflicting results, both decreased and increased, have been
reported concerning the function of T-lymphocytes in heroin
addicts. We investigated the alterations of T-lymphocyte pro-
liferative responses and immunophenotypic markers on lym-
phoid cells in heroin addicts and during different periods of
heroin withdrawal in addicted subjects. This study has demon-
strated a decrease in the response of T-lymphocytes to 1.2,
2.5, 5 and 10 mg/ml of phytohemagglutinin stimuli in heroin
addicts and 1- to 5-day heroin withdrawal subjects compared
with controls. Similarly, in an in vitro study, 10
24,1 0
26 and
10
28 M concentrations of morphine were shown to suppress
0.6 and 2.5 mg/ml of PHA-stimulated T-lymphocyte obtained
from naive subjects. This inhibitory effect of morphine on PHA
stimulation was completely abolished by 100 mM naloxone. The
immunological parameters of total T-lymphocytes (CD3), T-
helper cells (CD4), cytotoxic T-cells (CD8), B-cells and natural
killer cells that are the immunophenotypic markers studied by
flow cytometric analysis were altered in heroin addicts, 15- to
21-day and 6- to 24-month heroin withdrawal subjects, when
compared with controls. These results suggest that heroin ad-
dicts and short period (15 to 21 days and 6 to 24 months) of
heroin withdrawal have decreases in their immune system func-
tioning and that the heroin withdrawal subjects seem to grad-
ually reverse their immunological parameters to normal levels
when withdrawal was sustained $2 years. This is the first report
examining immune function in heroin withdrawal subjects using
the “cold turkey” method. The results are beneficial for further
study of the mechanism responsible for the opioid-induced
changes in immune function.
Because of the AIDS epidemic, interest in studying the
effects of drugs of abuse, especially opiates, on the immune
system has increased greatly. This issue is now of paramount
importance because of the association of AIDS with intrave-
nous drug abuse. Heroin abusers are a high-risk group for
the development of AIDS and HIV infection. Intravenous
drug abusers account for 7.3% of the total AIDS cases in
Thailand (Wongkhomthong et al., 1995). Indeed, the HIV-
seropositivity rate among intravenous drug abusers can be
even greater, ranging from 5% in certain areas to 75% in
others (Curran et al., 1984), and this group is generally
regarded as posing the most substantial risk of furthering
spread of the disease. Even in the absence of AIDS, increas-
ing evidence indicates that chronic use of opioid drugs can
affect the functioning of the immune system. Heroin addicts
have an increased susceptibility to a variety of infectious
diseases (Louria et al., 1967), and alterations in a wide vari-
ety of immune parameters also have been reported among
them (for reviews, see Rouveix, 1992; Sibinga and Goldstein,
1988; Carr et al., 1996).
A variety of changes in the immune system have been
observed, indicative of both decreased and increased func-
tioning in heroin addicts. The absolute number and percent-
age of total and active T lymphocytes in the peripheral blood
of opiate addicts and T-cell rosette formation were signifi-
cantly depressed (McDonough et al., 1980). In contrast, an
increase in the absolute number of T-cells in the blood of
heroin addicts who were not malnourished was reported in
another study (Heathcote et al., 1981). Similar conflicting
results have been reported concerning the functional activity
of T lymphocytes from heroin addicts. Brown et al. (1974)
found impaired in vitro responsiveness of lymphocytes to
each of the three mitogens (PHA, concavanalin A, pokeweed
mitogen) in heroin addicts relative to control values. Simi-
larly, a suppressed PHA response in methadone patients was
reported (Quagliata et al., 1977); but Reddy et al. (1987)
found normal T-proliferative responses to both concavanalin
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 A and tetanus toxoid antigen in another group of healthy
addicts.
Immunophenotypic markers on lymphoid cells in human
addicts have been studied using flow cytometric analysis.
There was a profound decrease in the T-helper/cytotoxic T-
cell (CD4/CD8) ratio in heroin addicts (Donahoe et al., 1987).
Shine et al. (1987) found a normal pattern of T-cell subsets
and a normal CD4/CD8 ratio in another group of healthy
intravenous drug abusers and methadone patients. Most of
the data have suggested that opiates are involved in the
cell-mediated immune responses in heroin addicts. However,
data of immune responses in heroin-withdrawal subjects
during various withdrawal periods are not available at this
moment. Thus, the evidence for the immunomodulatory, and
even the immunocompromising potential of opioids is com-
pelling. Still, our understanding of the effects of opioids on
the immune system is incomplete. Controversial results, in
part, may be due to the specific mechanisms responsible for
morphine-induced changes in the immune system being un-
defined. In addition, most of the heroin addicts are polydrug
users. It is necessary to better understand the way in which
heroin modulates immune responses, as well as the relation-
ship between these effects, and to investigate whether this
results in increased susceptibility to infections. We focused
our attention on studies of the heroin-addicted and heroin
withdrawal subjects by considering the lymphocyte prolifer-
ative responses, the expression of total T lymphocytes (CD3),
T-helper cells (CD4), cytotoxic T-cell (CD8) antigenic mark-
ers of T-cells, B cells and NK cells. We conducted studies in
humans because humans are significantly different from
even the closest primates, and certainly profoundly different
from rodents, with respect to certain specific immune indices
and the pharmacokinetics of many drugs, as well as neuroen-
docrine functions. This is the first study of the immune
function in heroin withdrawal subjects who used the “cold
turkey” method, with no supplement of methadone or other
drugs in the withdrawal period.
Methods
Subject selection. Subjects consisted of parenteral heroin abus-
ers and heroin withdrawal subjects from Thanyarak Hospital, which
is one of the biggest hospitals in Thailand, with ;100 to 200 cases of
outpatient drug abusers daily. All subjects were men, aged 20 to 40
years, and none had recent infections, active inflammatory disease or
a positive HIV or HBsAg test. They were free of drugs affecting the
immune system and had no history of neuropsychiatric disorders.
Subjects participating in this study gave written informed consent.
All of the parenteral heroin abusers were selected from those who
had a history of intravenous injection of heroin for $1 year, with a
daily heroin dosage of not less than 600 mg. They absolutely did not
abuse other drugs. The heroin withdrawal subjects used the “cold
turkey” method for withdrawal from heroin, after which they expe-
rienced “craving” with some withdrawal symptoms, such as rhinor-
rhea, lacrimation, piloerection, restlessness, irritability, insomnia,
abdominal cramps, muscle “bone” aches and so on. They were free of
drugs for suppressing the withdrawal symptoms.
Serum and urine analyses. Blood and urine from volunteers in
all groups of this study were obtained between 9:00 to 11:30 a.m.
Blood was collected into polyethylene tubes containing 1000 U/ml
heparin. Routine medical and immunological histories were obtained
from all subjects. Routine urine analysis was performed, emphasiz-
ing the measurement of type and quantity of substances abused.
Urine morphine was reported positive by a cutoff limit at .5.50
mg/ml. Sera from all subjects were tested for HIV antibodies using a
particle-agglutination test for screening of antibodies to HIV (Sero-
dia-HIV, Tokyo, Japan) at Thanyarak hospital and double-checked
by using MICRO RED kit (BioRad, Hercules, CA) for screening of
HIV-1/HIV-2 antibodies in our laboratory. Blood chemistry studies to
assess hepatitic function were determined in all subjects.
Lymphocyte cultures. Freshly drawn venous blood (10 ml) from
subjects was diluted 1:1 with Hanks’ balanced salt solution. The cell
suspension (20 ml) was layered on 4 ml of Ficoll-paque solution
(Pharmacia, Uppsala, Sweden) (specific gravity, 1.083) for separa-
tion of lymphocytes according to the method of Sacerdote et al.
(1991). After centrifugation at 600 3 g for 20 min, the layer contain-
ing lymphocytes was transferred to another centrifuge tube, washed
twice in 10 ml of Hanks’ balanced salt solution and then centrifuged
at 1200 3 g for 10 min. The cells were resuspended again with RPMI
media containing 10% heat-inactivated fetal calf serum, 100 IU/ml
penicillin, 100 mg/ml streptomysin, 1% L-glutamine (Sigma Chemi-
cal, St. Louis, MO) and 1 mM HEPES (Sigma). Then, the suspension
was centrifuged at 1200 3 g for 10 min. The pellets were lympho-
cytes that were brought to culture for studying proliferation.
Lymphocyte cells were counted with the viable dye, 0.1% trypan
blue (Sigma) and adjusted to a final concentration of 1 3 10
6 cells/ml
in RPMI media. Triplicate cultures containing 2 3 10
5 cells in 200 ml
of RPMI media/well were seeded onto 96-microwell plates and
treated with a mitogen, PHA (Seromed, Berlin, Germany), in con-
centrations of 1.2, 2.5, 5 and 10 mg/ml. Lymphocyte cultures were
incubated for 48 hr at 37°C in 5% CO2 and aired in a humidified
incubator. After incubation, cells were pulsed for an additional 18 hr
with 1 mCi of [
3H]thymidine (2.0 Ci/mmol) (New England Nuclear,
Boston, MA). Cell proliferation was determined by the incorporation
of [
3H]thymidine into cellular DNA. A semiautomated cell harvest-
ing apparatus (Nunc, Naperville, CT) was then used to lyse the cells
with distilled water and precipitate the labeled DNA on glass filter
paper (Whatman, Clifton, NJ). The filter pads were dried, 1 ml of
scintillation fluid was added and then the radioactive material
trapped on filter paper was counted as cpm by a Beckman Instru-
ments (Columbia, MD) LS5000CE Scintillation Spectrometer. The
counting efficiency for tritium was ;45%.
Cell preparation for immunofluorescent staining in flow
cytometric studies. Peripheral blood samples were collected into
EDTA anticoagulant tubes and processed within 2 hr of collection.
All samples were prepared using lysed whole blood and stained with
the following panel of two-color antibody conjugates: LeucoGATE
(CD45FITC/CD14PE) [CD45/CD14], isotype control (IgG1FITC/
IgG1PE)[g1/g2], CD3FITC/CD16156PE(Leu4/11C119), CD3FITC/
CD19PE(Leu-4/12), CD3FITC/CD8PE(CD3/CD8)[Leu-4/2] and
CD3FITC/CD4PE (CD3/CD4) [Leu-4/3]. After a 15-min room temper-
ature incubation period, the red blood cells were lysed with FACS-
Lysing Solution (Becton Dickinson, San Jose, CA). Samples were
then fixed in a 1.0% paraformaldehyde solution before flow cytomet-
ric analysis.
Flow cytometric analysis. Flow cytometric studies were per-
formed on a FACScan Analyzer (Becton Dickinson, San Jose, CA).
The FACScan used an air-cooled argon ion laser with emission at 488
nm. The FACScan was calibrated using an automatic software, Au-
toCOMP and CaliBRITE beads. SimulSET software was used for
data acquisition and analysis, and LeucoGATE defined the lympho-
cyte gate, which included $95% of the total lymphocyte population.
Isotype controls defined autofluorescence and positioned the quad-
rant markers to calculate the percent positive cells for a given anti-
body.
Statistical analysis. Results were expressed as mean 6 S.E.M.
Student’s t tests were performed on continuous variables. For studies
involving multiple comparisons, data were analyzed by Tukey-
Kramer multiple comparison test.
884 Govitrapong et al. Vol. 286
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 Results
PHA-stimulated T lymphocyte proliferation in hero-
in-addicted and heroin withdrawal subjects. The base-
line characteristics of all subjects; normal (N; n 5 17), heroin
addicts (H; n 5 19) and heroin withdrawal subjects (HW; n 5
17) in the T-lymphocyte proliferation study are shown in
table 1. The ages of the subjects ranged from 22 to 28 years.
The dosage range of heroin that was used by heroin addicts
and heroin withdrawal subjects was 600 to 1200 mg/day. The
durations of heroin abuse were 2.95 6 0.53 and 1.36 6 0.18
years in heroin addicts and heroin withdrawal groups, re-
spectively. Urine morphine of .5.50 mg/ml was detected in
the heroin-addicted group.The duration of withdrawal peri-
ods ranged from 1 to 5 days. They all were negative in HIV
and HBsAg tests.
T-lymphocyte function was determined by the incorpora-
tion of [
3H]thymidine into the intracellular DNA of the cells
stimulated by PHA, a specific T-cell mitogen. The percentage
of T-lymphocyte proliferation compared with those of B-lym-
phocyte was .99%. T-lymphocytes obtained from normal,
heroin-addicted and heroin withdrawal subjects were prolif-
erated as a dose-dependent manner in the present of various
concentrations (1.2, 2.5, 5 and 10 mg/ml) of PHA (fig. 1). The
data represent the percentage of the control (unstimulated
cells of each group expressed as 100%). The proliferative
responses of the cells from heroin addicts in the presence of
1.2, 2.5, 5 and 10 mg/ml PHA in culture were suppressed
significantly compared with normal subjects. In the heroin
withdrawal (HW) group, significant immunosuppression
(P , .01) was also found in cells stimulated by every concen-
tration of PHA. However, the [
3H]thymidine incorporation
into DNA of the cells obtained from heroin withdrawal sub-
jects was significantly increased (P , .01) compared with
those from the heroin-addicted (H) group. To determine the
possibly direct effect of morphine on lymphocyte function,
various concentrations of morphine were included in the
T-lymphocyte cultured cells from normal subjects. Morphine
concentrations ranging from 0.01 to 100 mM induced a sig-
nificant reduction (P , .05 and P , .01) in lymphocyte
[
3H]thymidine incorporation in cultures stimulated with
PHA 0.6 (fig. 2A) and 2.5 (fig. 2B) mg/ml, respectively.
To determine whether the inhibition of T-lymphocyte pro-
liferation by morphine was abolished by naloxone, an opioid
receptor antagonist, cells were cultured with 0.01, 1 and 100
mM morphine in the presence of 100 mM naloxone. The mor-
phine-induced inhibition on 2.5 mg/ml PHA-stimulated T-
lymphocyte proliferation was totally reversed by 100 mM
naloxone (fig. 3). A significant difference (P , .05) in T-
lymphocyte proliferations was shown when compared be-
tween each concentration of morphine group, with and with-
out naloxone, except those from the without-morphine-added
group (fig. 3).
Comparison of lymphocyte subsets among normal,
heroin-addicted and heroin withdrawal subjects. To
further evaluate the immunosuppressive responses in heroin
TABLE 1
Base-line characteristics (mean 6 S.E.) of normal, heroin addicts and
heroin withdrawal subjects in T-lymphocyte proliferation study.
Normal Heroin addicts Heroin
withdrawal
Sex Male Male Male
Number of subjects 17 19 17
Age (yr) 28.24 6 1.24 26.21 6 0.94 21.29 6 0.18
Urine morphine (mg/ml) Negative .5.50 Negative
Dosage of heroin abuse
(mg/day)
600–1200 600–1200
Duration of heroin
abuse (yr)
2.95 6 0.53 1.36 6 0.18
HIV test Negative Negative Negative
HBsAg test Negative Negative Negative
Withdrawal period 1–5 days
Fig. 1. Effect of 1.2, 2.5, 5 and 10 mg/ml of PHA on proliferation of
T-lymphocytes in normal (n 5 17), heroin-addicted (n 5 19) and heroin
withdrawal subjects (n 5 17). Cell proliferation of T-lymphocytes ex-
tracted from three different groups of subjects were assayed as described
in Materials and Methods. T-lymphocyte proliferation responses were
expressed as mean 6 S.E. of [
3H]thymidine incorporation into DNA
compared with each unstimulated cell group (as percent control).
a, Sig-
nificant difference between heroin-addicted and normal subjects (P ,
.05).
b, Significant difference between heroin-addicted and normal sub-
jects (P , .01).
c, Significant difference between heroin-withdrawal and
normal subjects (P , .01).
d, Significant difference between heroin-with-
drawal and heroin-addicted subjects (P , .01).
Fig. 2. Concentration-response effect of morphine on 0.6 (A) and 2.5 (B)
mg/ml PHA stimulated T-lymphocyte proliferation in normal subjects.
Cell proliferation was assayed using 1 3 10
6 cells/ml of lymphocyte cells
in 96-microwell plate containing varying concentrations of morphine
(0.01–100 mM) and PHA as indicated in a final volume of 200 ml. After
incubation (48 hr, 37°C 5% CO2), all cells were pulsed for an additional 18
hr with 1 mCi [
3H]thymidine, and the radioactivity associated with the
cells was determined. Data presented as mean 6 S.E. of triplicate deter-
minations from seven normal subjects.
a, Significant difference from
without morphine group (P , .05).
b, Significant difference from without
morphine group (P , .01).
1998 Immune Functions in Heroin Abusers 885
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 abusers and heroin withdrawal subjects during various peri-
ods of time, flow cytometric analysis was performed and
subjects were selected accordingly. The base-line character-
istics of all subjects: normal (N; n 5 17), heroin addicts (H;
n 5 15), 15- to 21-day heroin withdrawal (HW1; n 5 15), 6- to
24-month heroin withdrawal (HW2; n 5 16) and 3- to 5-year
heroin withdrawal (HW3; n 5 15), are shown in table 2. The
average age was between 21 to 31 years, with the same daily
doses of heroin use (range, 600-1200 mg/day). The average
durations of heroin abuse were 2.95 6 0.53, 1.90 6 0.78,
6.10 6 1.22 and 6.00 6 1.05 years in heroin addicts and in 15-
to 21-day (HW1), 6- to 24-month (HW2) and 3- to 5-year
(HW3) withdrawal groups, respectively. They all were free
from HIV and HBs infections. The mean 6 S.E.M. values of
percent and absolute numbers of lymphocyte and total T-
lymphocyte (CD3) obtained from various groups of subjects
are shown in figure 4, A–D. There was no significant differ-
ence in the percentages of lymphocytes and total T-lympho-
cytes among different groups compared with controls. How-
ever, the absolute numbers of lymphocytes (fig. 4B) and total
T-lymphocytes (CD3) (fig. 4D) were both significantly in-
creased in heroin addicts, gradually declining to normal lev-
els as heroin withdrawal progressed. The percentages of T-
helper cells (CD4) obtained from heroin addicts and short
period heroin withdrawal groups were significantly de-
creased, reverting to normal levels when heroin withdrawal
had continued for a longer period of time (6 months to 5
years) (fig. 5A). In contrast, the percentages of cytotoxic
T-cell (CD8) obtained from heroin addicts and short period
heroin withdrawal groups were significantly increased (P ,
.001), reverting to normal levels when heroin withdrawal had
continued for a longer period of time (fig. 5C). The absolute
Fig. 3. Concentration-response effect of morphine on 2.5 mg/ml PHA-
stimulated T-lymphocyte proliferation in normal subjects is shown in a
black bar with naloxone and in a white bar without naloxone. Cell
proliferation was assayed using 1 3 10
6 cells/ml of lymphocyte cells in 96
microwell plate containing naloxone (100 mM) 45 min before adding
morphine (0.01–100 mM). After incubation (48 hr, 37°C, 5% CO2), all cells
were pulsed for an additional 18 hr with 1 mCi of [
3H]thymidine, and the
radioactivity associated with the cells was determined. Data presented as
mean 6 S.E. of triplicate determinations from 10 normal subjects.
a,
Significant difference from without morphine group (P , .05).
b, Signifi-
cant difference from 0.01 mM morphine without naloxone group (P , .05).
c, Significant difference from 1 mM morphine without naloxone group
(P , .05).
d, Significant difference from 100 mM morphine without nal-
oxone group (P , .05).
TABLE 2
Base-line characteristics (mean 6 S.E.) of normal, heroin addicts and heroin withdrawal subjects in flow cytometric analysis
Normal Heroin addicts
Heroin withdrawal subjects
HW1 HW2 HW3
Number of subjects 17 15 15 16 15
Sex Male Male Male Male Male
Age (yr) 28.53 6 1.16 27.40 6 1.78 21.2 6 0.20 28.00 6 1.93 29.80 6 2.01
Urine morphine (mg/ml) Negative .5.50 Negative Negative Negative
Dosage of heroin abuse (mg/day) 600–1200 600–1200 600–1200 600–1200
Duration of heroin abuse (yr) 2.95 6 0.53 1.90 6 0.78 6.10 6 1.22 6.00 6 1.05
HIV test Negative Negative Negative Negative Negative
HBsAg test Negative Negative Negative Negative Negative
Withdrawal period 15–21 days 6–24 mo 3–5 yr
Fig. 4. Comparison of percentage of lymphocytes (A), absolute lympho-
cyte count (B), percentage of total T-lymphocytes [CD3] (C) and absolute
CD3 count (D) among normal (N; n 5 17), heroin addicts (H; n 5 15), 15-
to 21-day heroin withdrawal (HW1; n 5 15), 6- to 24-month heroin
withdrawal (HW2; n 5 16) and 3- to 5-year heroin withdrawal (HW3; n 5
15) subjects. The data were obtained by using a highly sensitive FACScan
flow cytometer. Each group presented as mean 6 S.E.
a, Significant
difference from normal group (P , .05).
886 Govitrapong et al. Vol. 286
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 numbers of CD8 in different groups of subjects were altered
in the same manner as the percents of CD8 (fig. 5D), whereas
the absolute numbers of CD4 in all cases did not show any
significant difference among groups (fig. 5B). The ratios of
T-helper/cytotoxic T-cell (CD4/CD8) were shown to be signif-
icantly decreased in heroin addicts (P , .001), in 15- to
21-day heroin withdrawal (P , .001) and in 6- to 24-month
heroin withdrawal (P , .05) compared with normal subjects,
whereas this ratio reversed to normal values in 3- to 5-year
heroin withdrawal subjects (fig. 5E). Both the percentage
(fig. 6A) and absolute numbers of B-cells (fig. 6B) obtained
from heroin addicts and 15- to 21-day heroin withdrawal
subjects were significantly increased (P , .01) compared with
those obtained from normal subjects, whereas the numbers
obtained from subjects during longer periods of heroin with-
drawal were comparable to those of normal subjects. The
percentage of NK cells (fig. 6C) obtained from heroin addicts
and the 15- to 21-day heroin withdrawal group were signifi-
cantly decreased (P , .05 and P , .01, respectively) com-
pared with normal subjects, whereas the absolute numbers of
NK cells (fig. 6D) from all groups of subjects were not signif-
icantly different. However, the percentage (fig. 6C) and ab-
solute number of NK cells (fig. 6D) in the 6- to 24-month
heroin withdrawal group were increased significantly (P ,
.05) compared with heroin-addicted subjects.
Discussion
Alteration of immune function in heroin addicts.
Opiates have been shown to produce effects on immune func-
tion in vivo (Weber and Pert, 1989), and clinical observations
that opiate addicts have increased susceptibility to infections
(Louria et al., 1967) were subsequently shown to be related to
deficits in immune function (Brown et al., 1974). Our study
has demonstrated a decrease in the response of T lympho-
cytes to a wide range of concentrations of mitogenic (PHA)
stimuli in heroin-addicted subjects. This data supports the
result from Roy et al. (1995), who demonstrated that chronic
morphine treatment in vivo inhibited PHA-IL1-activated
thymocyte proliferation. It has been proposed that the effects
of opioids on lymphocyte proliferation may operate via a
direct interaction with opioid receptors (Sibinga and Gold-
stein, 1988). To test the above hypothesis, the effect of mor-
phine in vitro has therefore been studied. Morphine attenu-
ated the mitogen-induced lymphocyte proliferation in a dose-
dependent manner. Roy et al. (1991) showed a suppressive
effect of chronic morphine treatment on macrophage colony
formation in bone marrow. In addition, morphine inhibited
Fig. 5. Comparison of percentage of T-helper [CD4](A), absolute CD4
count (B), percentage of T-suppressor [CD8] (C), absolute CD8 count (D)
and the T-helper/T-suppressor [CD4/CD8] ratio (E) among normal (N;
n 5 17), heroin addicts (H; n 5 15), 15- to 21-day heroin withdrawal
(HW1; n 5 15), 6- to 24-month heroin withdrawal (HW2; n 5 16) and 3-
to 5-year heroin withdrawal (HW3; n 5 15) subjects. The data were
obtained by using a highly sensitive FACScan flow cytometer. Each group
presented as mean 6 S.E.
a, Significant difference from normal group
(P , .05).
b, Significant difference from normal group (P , .01).
c, Highly
significant difference from heroin-addicted group (P , .001).
d, Signifi-
cant difference from heroin-addicted group (P , .01).
Fig. 6. Comparison of percentage of B-cell (A), NK cell (B), absolute
B-cell count (C) and absolute NK-cell count (D) among normal (N; n 5 17),
heroin addicts (H; n 5 15), 15- to 21-day heroin withdrawal (HW1; n 5
15), 6- to 24-month heroin withdrawal (HW2; n 5 16) and 3- to 5-year
heroin withdrawal (HW3; n 5 15) subjects. The data were obtained by
using a highly sensitive FACScan flow cytometer. Each group presented
as mean 6 S.E.
a, Significant difference from normal group (P , .05).
b,
Significant difference from normal group (P , .01).
c, Significant differ-
ence from heroin-addicted group (P , .05).
1998 Immune Functions in Heroin Abusers 887
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 proliferation of PHA-IL-1 activation of naive mice thymo-
cytes in a dose-dependent manner could be demontrated in
vitro (Roy et al., 1995). Our data also indicate that this
inhibitory effect was abolished by naloxone. However, our
unpublished observation showed that neither morphine nor
naloxone could significantly alter the background (without
PHA) proliferation of lymphocyte. Roy et al. (1996) and Wick
et al. (1996) demonstrated that morphine-mediated inhibi-
tion of Bac1.2 F5 macrophage in culture was partially revers-
ible by naloxone, and their previous experiment showed that
activation of thymocyte with PHA-IL1 in vitro resulted in a
dramatic increase in (
3H)-morphine specific binding (Roy et
al., 1992). Collectively, we suggest that PHA might induce
proliferation of different population of lymphocytes contain-
ing different affinities of opioid receptors that are more or
less sensitive to morphine.
Immunophenotypic markers on lymphoid cells have been
determined using flow cytometric analysis in heroin addicts.
There was a profound decrease in the proportion of CD4/CD8
and the percentage of CD4, with an increase in both the
percentage and absolute numbers of CD8 and the absolute
numbers of cell expressing CD3. The data obtained here are
parallel with the proliferative responses. However, Shine et
al. (1987) found a normal pattern of T-cell subsets in a group
of healthy intravenous drug abusers and methadone pa-
tients, whereas Sei et al. (1991) and Novick et al. (1989) found
that parenteral heroin abusers had higher absolute numbers
of CD4 cells in the peripheral blood.
NK cell activity mediated predominantly by large granular
lymphocytes is also regulated by opioid compounds. In vitro,
b-endorphin and met-enkephalin augmented NK activity in a
dose-dependent and naloxone-reversible fashion (Matthews
et al., 1983; Kay et al., 1984). Morphine was slightly suppres-
sive (Matthews et al., 1983), and DAMGO suppressed NK
activity (Weber et al., 1989). Shavit et al. (1986) have previ-
ously shown that opiates interacting with opiate receptors in
the brain are implicated in the suppression of NK activity.
Those authors suggested novel central nervous system mech-
anisms through which the immune response might be regu-
lated. In the present study, the percentage of NK cells was
suppressed in heroin addicts. This was supported by a pre-
vious study showing that parenteral heroin addicts had sig-
nificantly reduced NK activity while the absolute numbers of
NK cells in peripheral blood were unchanged (Novick et al.,
1989). The similar findings had previously been reported by
Reddy et al. (1987) and DePaoli et al. (1986), who observed
reduced NK cell activity in HIV-seronegative parenteral drug
addicts and a further reduction in HIV-seropositive patients.
The present study in heroin addicts has shown an increase
in both the number and the percentage of B cells by immu-
nofluorescence staining. Johnson et al. (1982) reported that
a-endorphin in vivo significantly depressed primary antibody
production to sheep red blood cells. Both met-enkephalin and
leu-enkephalin are modulate inhibitors, whereas b- and g-en-
dorphin are not effective. Morphine seems to have no effect
on antibody production where animals are immunized with a
T-independent antigen. However, in vivo administration of
b-endorphin inhibited the primary antibody response to key-
hole limpet hemocyanin but enhanced the secondary re-
sponse (Munn et al., 1989).
Immune status in heroin-withdrawal subjects. The
immune function in heroin withdrawal subjects also was a
focus of the present study. In most previous studies of heroin
addiction, the data were obtained from patients who were not
only polydrug abuses but also in the withdrawal state; most
patients were either treated with drugs to suppress with-
drawal symptoms, in methadone maintenance therapy or
both. The patients in our study not only were single-drug
abusers but, in the withdrawal state, also were free of any
drug, as heroin withdrawal was carried out “cold turkey.”
This would make our results extremely beneficial for the
better understanding of heroin withdrawal mechanisms. In a
previous study (Novick et al., 1989) of long-term stabilized
methadone-maintenanced patients, NK cell activity and ab-
solute B- and T-cell subset numbers were not significantly
different from those of normal control subjects. Kind (1988)
performed a study in unselected groups of former narcotic
addicts in methadone maintenance treatment for varying
periods of time, including patients both with and without
continuing polydrug and alcohol abuse. He found that 53% of
subjects had normal NK cell cytotoxicity. However, metha-
done itself has been shown to have immunomodulatory ef-
fects, and these effects are dose dependent. At doses below 75
mg/kg, it was possible to reverse the immunodepressive ef-
fect of heroin (Novick et al., 1989). In contrast, in an in vitro
study, Kind (1988) showed that neither opioid antagonist
(naloxone) nor opioid agonist (methadone) altered NK cyto-
toxicity until drug concentrations pf .10
24 M above phar-
macological levels were reached, at which point both com-
pounds reduced NK activity in parallel responses. In the
present study, the suppression of lymphocyte proliferation
responses was partially reversed in the heroin withdrawal
subjects. All parameters, assessed by flow cytometric analy-
sis, were altered in heroin addicts but gradually returned to
normal levels, with the exception of the short period of with-
drawal (15 to 21 days), where they seemed to get worse.
However, the total recovery in almost all immunological pa-
rameters obtained here would not occur before 3 to 5 years
after drug withdrawal. Our studies supported the notion that
“the time course of the development of tolerance following
initial drug exposure and the persistence of tolerance follow-
ing sudden removal of the drug was found to parallel the
development and decline of immune reactions” (Cochin and
Kornetsky, 1964). Our result clearly demonstrates that the
immunological deficits evidenced during drug consumption
are reversible slowly after heroin is withdrawn, without tak-
ing methadone and concomitantly in parallel with the decline
of the withdrawal signs and other neurobehavioral effects.
A considerable amount of evidence suggests that opioids
administrated in vivo modify the immune system indirectly.
The HPA axis has been implicated in the morphine-mediated
suppression of primary humoral immune responses (Pruett
et al., 1992). Other recent studies also suggest that mor-
phine-mediated effects on the immune system operates
through central processes (Hernandez et al., 1993; Fecho et
al., 1993). However, there was an indication that the HPA
axis was not necessarily involved in all opioid-mediated im-
munosuppressive effects because injection of opioid com-
pounds into specific sites of the brain that resulted in a
suppressive effect on immune function (e.g., lymphocyte pro-
liferation on splenic NK activity) did not change the circulat-
ing levels of corticosterone (Band et al., 1992; Hernandez et
al., 1993). Collectively, these results provide convincing evi-
dence for the local and systemic activity of opioids on immu-
888 Govitrapong et al. Vol. 286
 
b
y
 
o
n
 
M
a
y
 
2
4
,
 
2
0
0
9
 
j
p
e
t
.
a
s
p
e
t
j
o
u
r
n
a
l
s
.
o
r
g
D
o
w
n
l
o
a
d
e
d
 
f
r
o
m
 nocompetence and immune homeostasis. Attempts to defini-
tively prove of the existence of opioid receptors on cells of the
immune system have been unsucessful in various laborato-
ries, including our own by using radioligand binding. How-
ever, recently, molecular techniques have provided data
(Sedqi et al., 1995; Chuang et al., 1995; Wick et al., 1996; Roy
et al., 1996) indicating the existence of opioid receptors on
cells of the immune system.
In conclusion, the results from our study indicate a depres-
sion in PHA-stimulated T lymphocyte proliferation, both as
an in vitro effect of morphine and in heroin addicts, including
the modulation of surface markers observed on T cells. The
alteration of the T lymphocyte proliferative responses and
surface markers seems to gradually reverse to normal levels
when heroin is withdrawn. The mechanisms responsible for
the opioid-induced changes in immune function are still un-
clear. They may be mediated directly via opioid receptors
present on lymphocytes (Wick et al., 1996; Roy et al., 1996)
and/or indirectly via opioid receptors in the central nervous
system. Molecular biological and biochemical characteriza-
tions suggest that immune cell differentially express classic
opioid receptors. In addition, the presence of a novel class of
opioid receptor in immune cells has been suggested, and it is
believed that the antiproliferative effect is mediated via this
receptor type (Roy and Loh, 1996). However, multifactorial
elements might be involved in such alteration. Efforts should
be continued and expanded to facilitate an interchange of
new ideas that will accelerate research and lead to the more
rapid development of new and more effective treatments for
substance abuse.
Acknowledgments
We express their appreciation to the staff of Thanyarak Hospital
for their support, helpful cooperation and suggestions.
References
Band LC, Pert A, Williams W, DeCosta BR, Rice KC and Weber R (1992) Central
m-opioid receptors mediate suppression of natural killer activity in vivo. Prog
Neuroendocrinimmunol 5:95–101.
Brown SM, Stimmel B and Taub RN (1974) Immunologic dysfunction in heroin
addicts. Arch Intern Med 134:1001–1006.
Carr DJJ, Rogers TJ and Weber RJ (1996) The relevance of opioids and opioid
receptors on immunocompetence and immune homeostasis. Proc Soc Exp Biol Med
213:248–257.
Chuang LF, Chuang TK, Killam KF, Qui JQ, Wang XR, Lin JJ, Kung HF, Sheng W,
Chao C, Yu L and Chuang RY (1995) Expression of kappa opioid receptors in
human and monkey lymphocytes. Biochem Biophys Res Commun 209:1003–1010.
Cochin J and Kornetsky C (1964) Development and loss of tolerance to morphine in
the rat after single and multiple injections. J Pharmacol Exp Ther 145:1–10.
Curran JW, Lawrence DN, Jaffe H, Kaplan JE, Zyla LD, Chamberland M, Weinstein
R, Lui KJ, Schonberger LB and Spira TJ (1984) Acquired immunodeficiency
syndrome (AIDS) associated with transfusion. N Engl J Med 310:69–75.
DePaoli P, Reitano M and Battlinstin S (1986) Immunological abnormalities in
intravenous drug abuser and relationship to generalized lymphadenopathy in
Italy. Clin Exp Immunol 64:451–456.
Donahoe RM, Bueso-Ramos C, Donahoe F, Madden JJ, Falek A, Nicholson JKA and
Bokos P (1987) Mechanistic implications of the findings that opiates and other
drugs of abuse moderate T-cell surface receptors and antigenic markers. Ann NY
Acad Sci 496:711–721.
Fecho K, Dykstra LA and Lysle DT (1993) Evidence for beta adrenergic receptor
involvement in the immunomodulatory effects of morphine J Pharmacol Exp Ther
265:1079–1087.
Heathcote J and Taylor KB (1981) Immunity and nutrition in heroin addicts. Drug
Alcohol Depend 8:245–255.
Hernandez MC, Flores LR and Bayer BM (1993) Immunosuppression by morphine is
mediated by central pathways. J Pharmacol Exp Ther 267:1336–1341.
Johnson HM, Smith EM, Torres BA and Blalock JE (1982) Regulation of the in vitro
antibody response by neuroendocrine hormones. Proc Natl Acad Sci USA 79:4171–
4174.
Kay N, Allen J and Morley JE (1984) Endorphins stimulate normal human periph-
eral blood lymphocyte natural killer activity. Life Sci 35:53–59.
Kind P (1988) Basic immunology issues in drug abuse. NIDA Res Monogr 90:72–75.
Louria DB, Hensle T and Rose J (1967) The major medical complications of heroin
addiction. Ann Intern Med 67:1–22.
Matthews PM, Froelich CJ, Sibbit WJ and Bankhurst AD (1983) Enhancement of
natural cytotoxicity by beta-endophin. J Immunol 130:1658–1662.
McDonough RJ, Madden JJ, Falek A, Shafer DA, Pline M, Dordon D, Gokos P,
Kuehnle JC and Mendelson J (1980) Alteration of T and null lymphocyte frequen-
cies in the peripheral blood of human opiate addicts: In vivo evidence for opiate
receptor sites on T lymphocytes. J Immunol 125:2539–2543.
Munn NA and Lum LG (1989) Immunoregulatory effects of alpha-endorphin, beta-
endorphin, methionine-enkephalin adrenocorticotropic hormone on anti-tetanus
toxiod antibody synthesis by human lymphocytes. Clin Immunol Immunopathol
52:376–385.
Novick DM, Ochshornn M and Ghali V (1989) Natural killer cell and lymphocyte
subsets in parenteral heroin abuser and long term methadone maintenance pa-
tients. J Pharmacol Exp Ther 250:606–610.
Pruett SB, Han YC and Fuchs BA (1992) Morphine suppresses primary humoral
immune responses by a predominantly indirect mechanism. J Pharmacol Exp Ther
262:923–928.
Quagliata F, Melton R and Soika I (1977) Decrease response to mitogens and
impaired capping ability of lymphocytes in narcotic addiction. Clin Res 25:513A.
Reddy MM, Englard A, Brown D, Buimovici-Klien E and Grieco MH (1987) Lym-
phoproliferative responses to human immunodeficiency virus in asymptomatic
intravenous drug abusers and in patients with lymphodenopathy or AIDS. J Infect
Dis 156:374–376.
Rouveix B (1992) Opiates and immune function. Therapie 47:503–512.
Roy S, Ge BL, Loh HH and Lee NM (1992) Characterization of (
3H)-morphine
binding to interleukin-1 activated thymocyte. J Pharmacol Exp Ther 263:451–456.
Roy S, Loh HH and Barke RA (1995) Morphine-induced suppression of thymocyte
proliferation is mediated by inhibition of IL-2 synthesis. Adv Exp Med Biol 373:
41–48.
Roy S and Loh HH (1996) Effects of opioids on the immune system. Neurochem Res
21:1375–1386.
Roy S, Ramakrishanan S, Loh HH and Lee NM (1991) Chronic morphine treatment
selectively suppresses macrophage colony formation in bone marrow. Eur J Phar-
macol 195:359–363.
Roy S, Sedqi M, Ramakrishanan S, Barke RA and Loh HH (1996) Differential effects
of opioids on the proliferation of macrophage cell line Bac1.2F5. Cell Immunol
2:271–274.
Sacerdote P, Rubboli F, Locatelli L, Ciciliato I, Mantegazza P and Panerai AE (1991)
Pharmacological modulation of neuropeptides in peripheral mononuclear cells.
J Neuroimmunol 32:35–41.
Sei Y, Yoshimoto K, Meintyre T, Skolnick P and Arora PK (1991) Morphine-induced
thymic hypoplasia is glucocorticoid dependent. J Immunol 146:194–198.
Sedqi M, Roy S, Ramakrishnan S, Elde R and Loh HH (1995) Complementary DNA
cloning of a m-opioid receptor from rat peritoneal macrophages. Biochem Biophys
Res Commun 209:563–574.
Shavit Y, Depaulis A and Martin FC (1986) Involvement of brain opiate receptors in
the immune-suppressive effect of morphine. Proc Natl Acad Sci USA 83:7114–
7117.
Shine D, Moll B, Emeson E, Spigland I, Harris C, Small CB, Friedland G, Weiss SH
and Bodner AJ (1987) Serologic immunologic and clinical features of parenteral
drug users from contrasting populations. Am J Drug Alcohol Abuse 13:401–412.
Sibinga NE and Goldstein A (1988) Opioid peptides and opioid receptors in cell of the
immune system. Annu Rev Immunol 6:219–249.
Wick MJ, Minnerath SR, Roy S, Ramakrishnan S and Loh HH (1996) Differential
expression of opioid receptor genes in human lymphoid cell lines and peripheral
blood lymphocytes. J Neuroimmunol 64:29–36.
Weber RJ and Pert A (1989) The periaqueductal gray matter mediates opiate-
induced immunosuppression. Science 245:188–190.
Wongkhomthong SA, Kaime A and Ono K (1995) AIDS in the Developing World: A
Case Study in Thailand. Holistic Publishing, Bangkok.
Send reprint requests to: Piyarat Govitrapong, Ph.D., Neuro-Behavioural
Biology Center, Institute of Science and Technology for Research and Devel-
opment, Mahidol University at Salaya, Nakornpathom 73170, Thailand.
E-mail: grpkk@mahidol.ac.th
1998 Immune Functions in Heroin Abusers 889
 
b
y
 
o
n
 
M
a
y
 
2
4
,
 
2
0
0
9
 
j
p
e
t
.
a
s
p
e
t
j
o
u
r
n
a
l
s
.
o
r
g
D
o
w
n
l
o
a
d
e
d
 
f
r
o
m
 